Using PHMB antimicrobial to prevent wound infection

Wounds UK

Volumn 3, Issue 2, 2007, Pages 96-102

  Moore, Keith ^a   Gray, David ^a,b  

^a WoundsSci ^*

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

(PHMB); AMD wound dressings; Cost effectiveness; MRSA; Polyhexamethylene biguanide; Wound infection

Indexed keywords

IODINE; POLY(HEXAMETHYLENEBIGUANIDE); SILVER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG DELIVERY SYSTEM; DRUG INHIBITION; HOSPITALIZATION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; REVIEW; URINARY TRACT INFECTION; WOUND CARE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

EID: 34547634886     PISSN: 17466814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Beneke MJ, Doner J (2005) Observation of nosocomial surgical-site infection rates with utilisation of antimicrobial gauze dressing in an acute care setting. Presented at the 18th Annual Symposium on Advanced Wound Care, San Diego. www.kendallamd.com/pdf/H-5764ObservSSI_WP.pdf Last accessed 13th April 2007
2. Bowler P, Duerden B, Armstrong D (2001) Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14: 244-69
3. Brook I (1987) Microbiological studies of tracheostomy site wounds. Eur J Respir Dis 71: 380-3
4. Bruce J, Russell EM, Mollison J, Krukowski ZH (2001) The measurement and monitoring of surgical adverse events. Health Technol Assess 5(22): 1-194
5. Case JM (2000a) Microbial challenge test for porous materials using vancomycin resistant Enterococcus faecalis. Report prepared for Tyco Healthcare. www.kendallamd.com/pdf/h-5238. pdf Last accessed 11th April 2007
6. Case JM (2000b) Microbial challenge test for porous materials using vancomycin resistant Enterococcus faecalis. Report prepared for Tyco Healthcare. www.kendallamd.com/pdf/h-5237. pdf Last accessed 11th April 2007
7. Cazzaniga A, Serralta V, Davis S, Orr R, Eaglestein W, Mertz P (2000) The effect of an antimicrobial gauze dressing impregnated with 0.2% polyhexamethylene biguanide (PHMB) as a barrier to prevent Pseudmonas aeruginosa wound invasion. Wounds 14: 169-76
8. Coia JE, Duckworth GJ, Edwards DI et al (2006) Guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 63(Suppl 1): S1-44
9. Cooper RA (2005) Understanding wound infection. In: European Wound Management Association (EWMA). Position Document: Identifying Criteria for Wound Infection. MEP, London: 2-5
10. Cutting KF, Harding KG (1994) Criteria for identifying wound infection. J Wound Care 3: 198-201
11. Davenport K, Keeley FX (2005) Evidence for the use of silver-alloy-coated urethral catheters. J Hosp Infect 60(4): 298-303
12. Davis S, Mertz PM, Cazzaniga A, Serralta V, Orr R, Eaglstein W (2002) The use of new antimicrobial gauze dressings: effects on the rate of epithelialization of partial-thickness wounds. Wounds 14: 252-6
13. Gilbert P (2006) Avoiding the resistance pitfaf in infection control. Ostomy Wound Manage 52(10A Suppl): 1S-3S
14. Guyot A, Layer G (2006) MRSA - 'bug-bear' of a surgical practice: reducing the incidence of MRSA surgical site infections. Ann R Coll Surg Engl 88(2): 222-3
15. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12): 1551-7
16. Hutton CL (2005) The use of antimicrobial gauze packing in an infected coronary artery bypass graft surgical incision. Presented at 18th Annual Symposium on Advanced Wound Care, San Diego. www.kendallamd.com/pdf/H- 5762CoronaryBypassWP_000.pdf Last accessed 13th April 2007
17. Kingsley A (2001) A proactive approach to wound infection. Nurs Stand 15(30): 50-4, 56, 58
18. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ (1999) The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 20(11): 725-30
19. Larkin DF, Kilvington S, Dart JK (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmol 99(2): 185-91
20. Lee WR, Tobias KM, Bemis DA, Rohrbach BW (2004) In vitro efficacy of a polyhexamethylene biguanide-impregnated gauze dressing against bacteria found in veterinary patients. Vet Surg 33(4): 404-11
21. Marks J, Hughes LE, Harding KG, Campbell H, Ribeiro CD (1983) Prediction of healing time as an aid to the management of open granulating wounds. World J Surg 7(5): 641-5
22. McCauley RL, Linares HA, Pelligrini V, Herndon DN, Robson MC, Heggers JP (1989) In vitro toxicity of topical antimicrobial agents to human fibroblasts. J Surg Res 46(3): 267-74
23. McCullin C (2005) The use of an antimicrobial dressing to help improve outcomes for patients with pressure ulcers in a skilled nursing facility. Presented at Clinical Symposium for Advances in Skin and Wound care, Las Vegas. www.kendallamd.com/pdf/H-5780McCullin_WP.pdf Last accessed 11th April 2007
24. Motta GJ, Milne CT, Corbett LG (2004) Impact of antimicrobial gauze on bacterial colonies in wounds that require packing. Ostomy Wound Manage 50: 48-62
25. Motta GJ, Trigilia D (2005) The effect of an antimicrobial drain sponge dressing on specific bacterial isolates at tracheostomy sites. Ostomy Wound Manage 51: 60-6
26. Nixon M, Jackson B, Varghese P, Jenkins D, Taylor G (2006) Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control. J Bone Joint Surg Br 88(6): 812-7
27. Penn RG, Vyhlidal, Roberts S, Millers S (2006) The reduction of vascular surgical site infections with the use of antimicrobial gauze dressing. Report prepared for Tyco Healthcare. Presented at The Annual Conference of the Association for Professionals in Infection Control and Epidemiology, Tampa, USA. www.kendallamd.com/pdf/H-5883AMDVascSSIWP.pdf. Last accessed 11th April 2007
28. Percival SL, Bowler PG, Russell D (2005) Bacterial resistance to silver in wound care. J Hosp Infect 60(1): 1-7
29. Perwaiz S, Barakzi Q, Farooqi BJ, Khursheed N, Sabir N (2007) Antimicrobial susceptibility pattern of clinical isolates of methicillin resistant Staphylococcus aureus. J Pak Med Assoc 57(1): 2-4
30. Reitsma AM, Rodeheaver GT (2000) Effectiveness of a new antimicrobial gauze dressing as a bacterial barrier. Report prepared for Tyco Healthcare. www.kendallamd.com/pdf/EffecivenessofAMDdressingasabacterialbarrier-Rodeheaver. pdf Last accessed 11th April 2007
31. Robson M (1997) Wound Infection - A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 77: 637-50
32. Schultz GS, Sibbald RG, Falanga V et al (2003) Wound bed preparation: a systematic approach to wound management. Wound Repair Regen 11(Suppl 1): S1-S28
33. Selvaggi G, Monstrey S, Van Landuyt K, Hamdi M, Blondeel P (2003) The role of iodine in antisepsis and wound management: a reappraisal. Acta Chir Belg 103(3): 241-7
34. Shah CB (2000) Testing of antimicrobial efficacy of wound dressing by zone of inhibition. Report prepared for Tyco Healthcare. www.kendallamd.com/pdf/Zoifinal_000.pdf
35. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170(11): 5583-9
36. Thomas S, McGubbin P (2003) An in vitro analysis of the antimicrobial properties of 10 silver containing dressings. J Wound Care 12: 305-8
37. Werthen M, Davoudi M, Sonesson A Nitsche DP, Morgelin M, Blom K, Schmidtchen A. (2004) Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. J Antimicrob Chemother 54(4): 772-9
38. Ziegler K, Gorl R, Effing J et al (2006) Reduced cellular toxicity of a new silver-containing antimicrobial dressing and clinical performance in non-healing wounds. Skin Pharmacol Physiol 19(3): 140-6